Restricted Use of iNCOVACC for Booster Vaccination Approved
CDSCO has now also approved ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant COVID19Vaccine (iNCOVACC). This approval is extended to it as a Booster (third) dose vaccination for restricted use in emergencies. This vaccine can be administered intra-nasally.
CDSCO notifies COVID-19 vaccines approved for Manufacture for Sale or for Distribution
The CDSCO has approved COVISHIELD & COVAXIN vaccines for manufacture for sale or distribution in the country. It has also approved 15 more COVID-19 vaccines for Primary vaccination series for Restricted Use in Emergency Situation in the country.
